[HTML][HTML] The involvement of exosomes in glioblastoma development, diagnosis, prognosis, and treatment

A Bălașa, G Șerban, R Chinezu, C Hurghiș, F Tămaș… - Brain sciences, 2020 - mdpi.com
Brain tumours are a serious concern among both physicians and patients. The most feared
brain tumour is glioblastoma (GBM) due to its heterogeneous histology, substantial invasive …

[HTML][HTML] A systematic review and meta-analysis of supramarginal resection versus gross total resection in glioblastoma: can we enhance progression-free survival time …

J Wach, M Vychopen, A Kuehnapfel, C Seidel… - Cancers, 2023 - mdpi.com
Simple Summary Glioblastoma tumor cells are frequently found in areas distant from
conventional imaging abnormalities. These cells are thought to play a role in tumor …

Analysis of cell-free circulating tumor DNA in 419 patients with glioblastoma and other primary brain tumors

DE Piccioni, AS Achrol, LA Kiedrowski, KC Banks… - CNS …, 2019 - Taylor & Francis
Aim: Genomically matched trials in primary brain tumors (PBTs) require recent tumor
sequencing. We evaluated whether circulating tumor DNA (ctDNA) could facilitate genomic …

[HTML][HTML] Lightfield hyperspectral imaging in neuro-oncology surgery: an IDEAL 0 and 1 study

O MacCormac, P Noonan, M Janatka… - Frontiers in …, 2023 - frontiersin.org
Introduction Hyperspectral imaging (HSI) has shown promise in the field of intra-operative
imaging and tissue differentiation as it carries the capability to provide real-time information …

[HTML][HTML] Brain tumour post-treatment imaging and treatment-related complications

AT Kessler, AA Bhatt - Insights into imaging, 2018 - Springer
Purpose The imaging of primary and metastatic brain tumours is very complex and relies
heavily on advanced magnetic resonance imaging (MRI). Utilisation of these advanced …

[HTML][HTML] A comprehensive proteomic SWATH-MS workflow for profiling blood extracellular vesicles: a new avenue for glioma tumour surveillance

S Hallal, A Azimi, H Wei, N Ho, MYT Lee… - International journal of …, 2020 - mdpi.com
Improving outcomes for diffuse glioma patients requires methods that can accurately and
sensitively monitor tumour activity and treatment response. Extracellular vesicles (EV) are …

[HTML][HTML] The extracellular matrix and biocompatible materials in glioblastoma treatment

A Belousov, S Titov, N Shved, M Garbuz… - … in bioengineering and …, 2019 - frontiersin.org
During cancer genesis, the extracellular matrix (ECM) in the human brain undergoes
important transformations, starting to resemble embryonic brain cell milieu with a much …

Green nanomedicine: the path to the next generation of nanomaterials for diagnosing brain tumors and therapeutics?

E Mostafavi, D Medina-Cruz… - Expert opinion on …, 2021 - Taylor & Francis
Introduction: Current brain cancer treatments, based on radiotherapy and chemotherapy, are
sometimes successful, but they are not free of drawbacks. Areas covered: Traditional …

Prediction score for postoperative neurologic complications after brain tumor craniotomy: a multicenter observational study

R Cinotti, N Bruder, M Srairi, C Paugam-Burtz… - …, 2018 - pubs.asahq.org
Abstract Editor's Perspective What We Already Know about This Topic The authors
developed a score for predicting the risk of postoperative complications What This Article …

Significance of liquid biopsy in glioblastoma–A review

Á Klekner, L Szivos, J Virga, P Árkosy, L Bognár… - Journal of …, 2019 - Elsevier
Glioblastoma (GBM) is the most common and most aggressive primary malignant brain
tumor with a 16-24-months overall survival time (OS). Effective management is hindered by …